Olwen Hahn to Doxorubicin
This is a "connection" page, showing publications Olwen Hahn has written about Doxorubicin.
Connection Strength
0.028
-
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance). J Clin Oncol. 2015 Jan 01; 33(1):13-21.
Score: 0.028